Search This Blog

Thursday, February 27, 2020

Coherus BioSciences EPS misses by $0.17, beats on revenue

Coherus BioSciences (NASDAQ:CHRS): Q4 GAAP EPS of $0.53 misses by $0.17.
Revenue of $123.86M beats by $0.25M.
Press Release
https://seekingalpha.com/news/3546656-coherus-biosciences-eps-misses-0_17-beats-on-revenue
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)